These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7046135)

  • 1. Anti-erythrocyte antibodies, leukocytotoxins and human renal allograft survival.
    Etheredge EE; Bettonville P; Sicard GA; Anderson CB
    Tissue Antigens; 1982 Mar; 19(3):205-12. PubMed ID: 7046135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interdonor incompatibility due to anti-Kell antibody undetectable by automated antibody screening.
    West NC; Jenkins JA; Johnston BR; Modi N
    Vox Sang; 1986; 50(3):174-6. PubMed ID: 3716289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current experience with renal transplantation across the ABO barrier.
    Nelson PW; Helling TS; Shield CF; Beck M; Bryan CF
    Am J Surg; 1992 Nov; 164(5):541-4; discussion 544-5. PubMed ID: 1443385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-year outcomes following 1420 ABO-incompatible living-donor kidney transplants performed after ABO antibody reduction: results from 101 centers.
    Opelz G; Morath C; Süsal C; Tran TH; Zeier M; Döhler B
    Transplantation; 2015 Feb; 99(2):400-4. PubMed ID: 25050471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfusion-induced alloimmunization in patients awaiting renal allografts.
    Moore SB; Sterioff S; Pierides AM; Watts SK; Ruud CM
    Vox Sang; 1984; 47(5):354-61. PubMed ID: 6390955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eluate analysis of anti-Bg a associated renal allograft rejection.
    Frist S; Wenz B
    Transfusion; 1976; 16(3):261-6. PubMed ID: 59436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of Lewis and other blood group systems in kidney transplantation.
    Lenhard V; Hansen B; Roelcke D; Dreikorn K; Wernet P; Bockhorn H; Fassbinder W; Fetta RF; Wilms H; Gumbel B; Albert FW; Ewald RW; Sprenger-Klasen I; Goldmann SF
    Proc Eur Dial Transplant Assoc; 1983; 19():432-7. PubMed ID: 6348744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Red cell antibodies arising from solid organ transplants.
    Ramsey G
    Transfusion; 1991 Jan; 31(1):76-86. PubMed ID: 1986468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA.
    Solgi G; Furst D; Mytilineos J; Pourmand G; Amirzargar AA
    Transpl Immunol; 2012 Mar; 26(2-3):81-7. PubMed ID: 22182633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplantation of ABO A2 kidneys into O recipients: do IgM anti-A1 titers matter?
    Tierney J; Shaffer D
    Clin Transplant; 2015 Apr; 29(4):379-82. PubMed ID: 25659826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of humoral immunity to Lewis blood group antigens with renal transplant rejection.
    Spitalnik S; Pfaff W; Cowles J; Ireland JE; Scornik JC; Blumberg N
    Transplantation; 1984 Mar; 37(3):265-8. PubMed ID: 6367166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Good kidney transplant outcome in recipients with presensitization against HLA class II but not HLA class I.
    Süsal C; Opelz G
    Hum Immunol; 2004 Aug; 65(8):810-6. PubMed ID: 15336782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood transfusion complications due to Kell factor incompatibility of the transfused blood].
    Skachilova NN; Umnova MA; Morozova AD; Shakhsuvarov VD; Beliaev VV
    Probl Gematol Pereliv Krovi; 1982 Dec; 27(12):16-20. PubMed ID: 7156084
    [No Abstract]   [Full Text] [Related]  

  • 15. Dr(a) (Cromer-related blood group antigen)-incompatible renal transplantation.
    Nakache R; Levene C; Sela R; Kaufman S; Shapira Z
    Vox Sang; 1998; 74(2):106-8. PubMed ID: 9501409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-HLA-matched 3rd party vascular allograft in renal transplant may lead to sensitization against donor HLA.
    Watson H; Pande R; Farid S; Ecuyer C; Baker R; Clarke B; Ahmad N
    Clin Transplant; 2016 Nov; 30(11):1508-1512. PubMed ID: 27543781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood group antigen-targeting peptide suppresses anti-blood group antibody binding to antigen in renal glomerular capillaries after ABO-incompatible blood reperfusion.
    Yoneyama T; Hatakeyama S; Tobisawa Y; Yamamoto H; Imanishi K; Okamoto T; Tokui N; Sugiyama N; Suzuki Y; Kudo S; Yoneyama T; Hashimoto Y; Koie T; Kamimura N; Fukuda MN; Ohyama C
    Transplantation; 2013 Feb; 95(3):418-25. PubMed ID: 23274971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo survival of K:18 red cells in a recipient with anti-K18.
    Barrasso C; Baldwin ML; Drew H; Ness PM
    Transfusion; 1983; 23(3):258-9. PubMed ID: 6679384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABO-incompatible renal transplantation at Tokyo Women's Medical University.
    Tanabe K; Tokumoto T; Ishida H; Toma H; Nakajima I; Fuchinoue S; Teraoka S
    Clin Transpl; 2003; ():175-81. PubMed ID: 15387109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
    Galili U
    Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.